Recro Pharma's non-opioid pain shot fails to get approval from FDA

(Reuters) - Recro Pharma's IV meloxicam, a non-opioid injection, did not get approval from the U.S. Food and Drug Administration because the agency said the drug's pain-relieving effect did not meet its expectations.